Apax Disbands Healthcare Team

Apax Partners has decided to halt new investments into health care assets as the private equity firm sees fewer opportunities in the industry.

The buyout firm will no longer have a dedicated health care team as a result and reassign almost all of the members to other roles, according to an update to its limited partners seen by Bloomberg News. Andrew Cavanna, one of the firm’s partners overseeing health care investment, has become head of investor relations for Americas, according to Apax’s website.

Apax said the remaining health care portfolio companies will continue to be managed by the broader team, while the firm will keep investing in “health care-adjacent” businesses.

“Business quality in health care is more variable due to reimbursement and regulatory pressures, supply shocks, capex intensity, and ‘stroke-of-the-pen’ risk, among other factors,” Apax Co-Chief Executive Officers Andrew Sillitoe and Mitch Truwit said in the investor note. “The heterogeneity of the sector has also provided fewer opportunities for us to leverage our repeatable playbooks.”

Apax has raised $80 billion in capital with offices in New York, London, Hong Kong, Mumbai, Munich, Shanghai and Tel Aviv, its website shows. The private equity firm will focus exclusively on the technology, services and internet consumer sectors going forward, according to its update.

14 Comments
 

Interesting, it looks like they’ve allocated the team to services and tech which will have  organisational impact as a bunch of principals in those teams have more people to compete with for partner slots. 
 

healthcare is interesting at the MFs - if you go on Advents portfolio they haven’t completed a European healthcare deal in 5 years yet have a large European team presumably all making serious cash - makes you wonder 

 

Probably depends on what sectors of healthcare the firms were investing in. Traditional provider businesses in MSO - PC structures that were the bread and butter of healthcare PE are going to be tough for a while given regulatory / social headwinds. Lot of people piling into pharma services and HCIT though.

 
Most Helpful

Just want to get a sense from the more experienced PE folks here - do you think the disbanded HC personnel will really stay with Apax and grow into their new roles, or will they find other HC roles/get pushed out gradually by Apax?

Just asking cos I know if it was my firm, virtually all the ex-HC folks would be announcing their departure within a few months, one way or another. Seeing this happen now in fact...

 

Et dicta eum ab amet. Voluptas mollitia unde magnam. Similique officiis minima qui accusamus occaecati ut. Iure nisi nihil placeat blanditiis qui aperiam. Sed nam fuga vero tempora et voluptatem aperiam. Veritatis quia est qui et quia commodi.

Ut eligendi consequatur sint veniam dolore. Consectetur culpa velit tempore consectetur. Velit praesentium ducimus omnis voluptates. Et quas veniam quo commodi.

Sint consequuntur atque voluptatem aut. Ut dolor vitae praesentium accusantium alias. Consequatur iusto quidem odio quo similique ad eos. Et hic soluta velit et nihil distinctio quo.

Omnis eum nam id est corrupti earum. Alias in eius possimus corporis.

Career Advancement Opportunities

July 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.1%

Overall Employee Satisfaction

July 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.2%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Starwood Capital Group 98.1%

Professional Growth Opportunities

July 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.3%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • Vista Equity Partners 98.1%

Total Avg Compensation

July 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (99) $363
  • 3rd+ Year Associate (104) $281
  • 2nd Year Associate (235) $272
  • 1st Year Associate (411) $229
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (272) $124
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (356) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
GameTheory's picture
GameTheory
98.9
7
DrApeman's picture
DrApeman
98.9
8
dosk17's picture
dosk17
98.9
9
CompBanker's picture
CompBanker
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”